Hot Features
Premium
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Period:
Draw Mode:
| Volume | 504 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Illumina Inc | ILMN | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 123.05 | 08:27:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 123.05 |
| Trades | Shares Traded | Average Volume | 52 Week Range |
|---|---|---|---|
| 14 | 504 | - | 89.00 - 213.91 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 08:15:25 | 1 | US$ 120.72 | USD |
Illumina (ILMN) Options Flow Summary
Illumina Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 19.55B | 158.90M | - | 4.5B | -1.16B | -7.31 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Illumina News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ILMN Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 123.10 | 126.16 | 116.91 | 122.80 | 1,018,110 | -0.05 | -0.04% |
| 1 Month | 127.20 | 135.26 | 115.73 | 124.25 | 1,452,295 | -4.15 | -3.26% |
| 3 Months | 145.09 | 147.6999 | 115.73 | 132.63 | 1,630,694 | -22.04 | -15.19% |
| 6 Months | 108.80 | 148.19 | 89.00 | 123.26 | 2,158,899 | 14.25 | 13.10% |
| 1 Year | 205.46 | 213.91 | 89.00 | 143.57 | 1,861,871 | -82.41 | -40.11% |
| 3 Years | 393.48 | 526.00 | 89.00 | 218.08 | 1,376,540 | -270.43 | -68.73% |
| 5 Years | 311.77 | 555.77 | 89.00 | 257.94 | 1,277,340 | -188.72 | -60.53% |
Illumina Description
| Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications. |
